These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10876047)

  • 1. (Tyr(0),Bpa(4))bombesin is a GRP receptor agonist.
    Casibang M; Moody TW
    Peptides; 2000 May; 21(5):649-53. PubMed ID: 10876047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
    Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
    J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolism of BW2258U89, a GRP receptor antagonist.
    Marquez C; Treston A; Moody E; Jakowlew S; Moody TW
    Neuropeptides; 2000 Apr; 34(2):108-15. PubMed ID: 10985927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides.
    Sekar MC; Uemura N; Coy DH; Hirschowitz BI; Dickinson KE
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):163-9. PubMed ID: 1720612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BW 1023U90: a new GRP receptor antagonist for small-cell lung cancer cells.
    Moody TW; Venugopal R; Hu V; Gozes Y; McDermed J; Leban JJ
    Peptides; 1996; 17(8):1337-43. PubMed ID: 8971929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
    Benya RV; Wada E; Battey JF; Fathi Z; Wang LH; Mantey SA; Coy DH; Jensen RT
    Mol Pharmacol; 1992 Dec; 42(6):1058-68. PubMed ID: 1336112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
    Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
    Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth.
    Moody TW; Venugopal R; Zia F; Patierno S; Leban JJ; McDermed J
    Life Sci; 1995; 56(7):521-9. PubMed ID: 7869832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells.
    Weber HC; Walters J; Leyton J; Casibang M; Purdom S; Jensen RT; Coy DH; Ellis C; Clark G; Moody TW
    Eur J Pharmacol; 2001 Jan; 412(1):13-20. PubMed ID: 11166731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF.
    Burghardt B; Wenger C; Barabás K; Rácz G; Oláh A; Flautner L; Coy DH; Gress TM; Varga G
    Peptides; 2001 Jul; 22(7):1119-28. PubMed ID: 11445243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
    Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
    Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
    Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
    J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of receptor and protein kinase C activation in the internalization of the gastrin-releasing peptide receptor.
    Williams BY; Dion SB; Schonbrunn A
    Mol Pharmacol; 1998 Nov; 54(5):889-98. PubMed ID: 9804624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of bombesin constrained analogues.
    Cristau M; Devin C; Oiry C; Chaloin O; Amblard M; Bernad N; Heitz A; Fehrentz JA; Martinez J
    J Med Chem; 2000 Jun; 43(12):2356-61. PubMed ID: 10882361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bombesin receptor antagonists may be preferable to agonists for tumor targeting.
    Cescato R; Maina T; Nock B; Nikolopoulou A; Charalambidis D; Piccand V; Reubi JC
    J Nucl Med; 2008 Feb; 49(2):318-26. PubMed ID: 18199616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
    Wu JM; Hoang DO; Feldman RI
    Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.
    Nock BA; Nikolopoulou A; Galanis A; Cordopatis P; Waser B; Reubi JC; Maina T
    J Med Chem; 2005 Jan; 48(1):100-10. PubMed ID: 15634004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.